Cambridge Cancer Genomics
CCG.ai exist to ensure that each patient has the right drug, at the right time, to beat their cancer. We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance. We are expanding our team in Cambridge,
Y Combinator
yc-company-directory #1282CCG.ai exist to ensure that each patient has the right drug, at the right time, to beat their cancer. We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance. We are expanding our team in Cambridge,
sourceCambridge Cancer Genomics is classified as AI infrastructure from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.
Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.
Companies similar to Cambridge Cancer Genomics
A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.
Blank Bio
match 65Blank Bio is an applied AI research lab focused on increasing the success rates of clinical trials. We do this by training RNA foundation models that learn the patterns that shape disease progression and patient response to treatment. We aim to help pharma make more informed decisions in clinical trials by capturing the biology that makes each patient’s tumour unique. We’re a technical team of AI scientists and engineers from companies including Recursion, Deep Genomics, DeepMind, and Amazon, an
shared product terms: increas, clinical, patient, response; shared product theme: health and clinical care; same category: AI infrastructure; shared affiliation: Y Combinator
We Are Here
match 58We Are Here's AI driven cancer navigation platform enables customers to offer all patients: navigation support day one of diagnosis; expanded navigation, including assistance with cancer's impact on finances and distress; and, a custom experience.
shared extracted concept terms: driven; shared product terms: patient, cancer, enable, driven; shared product theme: health and clinical care; same category: AI infrastructure
Slideflow Labs
match 57Slideflow Labs brings the latest foundation models and cutting-edge methods, enabling customers to build & deploy digital biomarkers for molecular target identification, risk stratification, and treatment response prediction.
shared extracted concept terms: biomarker, treatment, response; shared product terms: biomarker, treatment, response; same category: AI infrastructure
Oncobox
match 56Oncobox believes that many late-stage cancer patients are dying prematurely because doctors lack a data-driven tool to help them decide which drugs currently on the market would most effectively fight individual patients’ specific cancers. That’s where Oncobox comes in. Oncobox is low-cost personalized genetic profiling to help doctors decide which drug to use. In a recent study conducted by leading cancer researchers in Europe and Asia on 900 patients with various late-stage cancers, Oncobox in
shared extracted concept terms: driven; shared product terms: patient, drug, cancer, driven; shared product theme: health and clinical care; shared affiliation: Y Combinator
Keylika
match 56Keylika is an early stage biopharma startup developing metal-based drugs using a platform synthesis technology to treat unmet medical needs. We then administer these drugs using proven delivery technologies to effect the best clinical outcomes. Our first product is a small molecule iron drug (new molecular entity) delivered by a wearable skin patch to treat Iron Deficiency Anemia (IDA), with significantly higher safety, efficacy and tolerability over existing treatments. This is poised to be a b
shared extracted concept terms: treatment; shared product terms: exist, drug, develop, treatment; shared product theme: health and clinical care; shared affiliation: Y Combinator
First Ascent Biomedical
match 50We provide a SaMD service in a SaaS model that delivers AI-driven patient-specific cancer treatment plans in 3-4 weeks.
shared extracted concept terms: driven; shared product terms: patient, cancer, driven, treatment; shared product theme: health and clinical care; same category: AI infrastructure